Egyptian Drug Authority Strengthens African Cooperation to Localize Vaccine Manufacturing
The Egyptian Drug Authority (EDA) participated in the activities of the fifth edition of the Africa Health ExCon 2026, which aims to enhance health cooperation among the continent's nations. Dr. Ali Al-Ghamrawy, Chairman of the Authority, represented the EDA at the signing ceremonies of several important strategic agreements.
These partnerships focus primarily on localizing the vaccine industry within Egypt and the African continent. The initiative aims to transfer advanced medical technology, which helps reduce reliance on imports and provide essential medicines and vaccines to citizens at affordable prices.
These steps seek to strengthen health security in Egypt and Africa by building strong local manufacturing capabilities. The Authority emphasizes that these agreements are part of the Egyptian state's vision to support the health sector and develop pharmaceutical industries to become a regional hub in this field.
At the conclusion of the events, officials pointed to the importance of continuing this international cooperation to ensure that future health challenges are addressed. These partnerships are considered a positive step toward achieving self-sufficiency in the field of vaccines, which contributes to improving the quality of healthcare for millions in the region.